HOYA Cura della vista, leader nell'innovazione tecnologica ottica, ha condiviso i risultati di uno studio clinico di follow-up triennale sul suoMiYOSMARTlenti per occhiali con tecnologia brevettata Defocus Incorporated Multiple Segments (D.I.M.S.) dopo aver rilasciato le informazioni alla recente conferenza dell'European Academy of Optometry and Optics (EAOO) 21.Ilnuovo studio, pubblicato nelMarzo 2021nel British Journal of Ophthalmology, was conducted by the Centre for Myopia Research at The Hong Kong Polytechnic University and follows-up on the two-year study which previously demonstrated evidence of the effectiveness of the lens in slowing down the progression of myopia in children ages 8-131.

Lo studio di follow-up di tre anni, condotto su 120 bambini inAsia, included 65 from the original group using MiYOSMART lens who took part in the previous study and 55 children who moved from using a single-vision lens for two years to the MiYOSMART lens in the third yearAlla fine del terzo anno, results in the original group of children using MiYOSMART lens showed that slowing in myopia progression over time was sustained and the group that moved from regular single-vision to MiYOSMART spectacle lens showed a significant and immediate slow-down in the progression of myopia.